As one of the leading economies in the world, the U.K. offers exposure to a range of sectors. Following Brexit and a successful COVID-19 vaccination rollout, the U.K. economy rebounded in 2021 and positive economic growth prospects seem likely.
The FTSE UK Index Series (calculated by FTSE Russell) is designed to represent the performance of U.K. companies, providing market participants with a comprehensive and complementary set of indexes that measure the performance of all capital and industry segments of the U.K. equity market. The FTSE UK Index Series includes well-known indices such as the FTSE 100 and FTSE 250. The indices are long established among institutional and retail investors as the standard measure of the country’s equity market health. Learn more about the FTSE UK Index Series.
ICE offers the broadest suite of highly liquid, cost-effective and margin-efficient tools for managing U.K. equity risk across FTSE 100, FTSE 250 futures and options and FTSE 100 Dividend Futures. Access contract specifications.
The index constituents are the largest 100 listed companies in the U.K.. ICE offers futures and options on the FTSE 100 Index, FTSE 100 Total Return Index and the FTSE 100 Dividend Indices. In addition, ICE offers weekly options and flexible longer-dated options (expiries out to 10.5 years) on the FTSE 100 Index.
The index covers a range of sectors, as mid-cap stocks they are small enough to experience strong earnings growth but still mature companies that are stable. Experience cost efficiency with margin offsets available against the entire suite of FTSE products. ICE offers futures and flexible options on the FTSE 250 Index.
FTSE 100 Futures, FTSE 250 Futures and FTSE 100 Dividend Futures (“the futures contracts”) have all been granted U.S. regulatory approval which means the futures contracts can be made available for offer and sale to U.S. persons and traded directly from the United States.
FTSE 100 Options and FTSE 250 Options are “Eligible Options” (as referred to in ICE Future Europe Circular 14/138, issued on Monday 27 October 2014) in respect of the transaction of business with specified U.S. entities.